ArticleFrontiers in bioengineering and biotechnology2022

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

Shuting Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.